1. Home
  2. Research
  3. COVID-19

NIDCR COVID-19 Funding Opportunities

NIDCR is funding research into COVID-19. Dena Fischer, DDS, MSD, MS, NIDCR's Director of the Center for Clinical Research, explains the different funding mechanisms currently available to the research community. If you wish to only view a particular question and answer, follow the links below the video:

Current Funding Opportunities

Title Staff Contact Opportunity Number Activity Code First Application Due Date
Notice of Special Interest (NOSI): Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities NOT-MD-21-008 R01 02/05/2021
Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional) PAR-20-243 R01

03/02/2021
Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE Project Jason Wan, PhD
(301) 594-9898		 NOT-OD-20-129 multiple, see announcement

03/12/2021

07/12/2021
Notice of Special Interest (NOSI): NIDCR Support for Research on the Physiological Involvement of Oral Cavity in Coronavirus Disease 2019 (COVID-19) NOT-DE-21-001 R01, R21 06/05/2021

Previous Funding Opportunities

Title Staff Contact Opportunity Number Activity Code First Application Due Date
Notice of Special Interest (NOSI): Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations Elise Rice, PhD
(301) 594-4814		 NOT-OD-20-119 multiple, see announcement 7/08/2020
Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations Elise Rice, PhD
(301) 594-4814		 NOT-OD-20-120 multiple, see announcement 7/08/2020
Notice of NIDCR's Participation in PA-20-135 "Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)" NOT-DE-20-030 N/A N/A
Notice of Special Interest (NOSI): Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations NOT-OD-20-121 multiple, see announcement 8/07/2020
Emergency Awards: RADx-UP Coordination and Data Collection Center (CDCC) (U24 Clinical Trial Optional) Dorothy Castille
(301) 594-9411

Darien Weatherspoon, DDS, MPH
(301) 594-5394		 RFA-OD-20-013 U24 8/07/2020
NIH Director’s Emergency Early Independence Awards (DP5 Clinical Trial Optional)

Lillian Shum, PhD

(301) 204-0908		 RFA-RM-20-021 DP5 9/04/2020
Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Chemosensory Testing as a COVID-19 Screening Tool Amanda Melillo, PhD
(301) 312-9037		 NOT-OD-20-152 Admin Supp 9/15/2020
Emergency Awards: Chemosensory Testing as a COVID-19 Screening Tool (U01 Clinical Trial Optional) Amanda Melillo, PhD
(301) 312-9037		 RFA-OD-20-022 U01 9/15/2020
Emergency Awards RADx-RAD: Screening for COVID-19 by Electronic-Nose Technology (SCENT) (U18 Clinical Trial Not Allowed) Orlando Lopez, PhD
(301) 402-4243		 RFA-OD-20-017 U18 9/18/2020
Emergency Awards: Exosome-based Non-traditional Technologies Towards Multi-Parametric and Integrated Approaches for SARS-CoV-2 (U18 Clinical Trial Not Allowed) Preethi Chander, PhD
(301) 827-4620		 RFA-OD-20-018 U18 9/18/2020
Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (Fast-Track STTR Clinical Trial Not Allowed)

Orlando Lopez, PhD
(301) 402-4243

 RFA-OD-20-021 R42 9/18/2020
Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (R44 Clinical Trial Not Allowed) Orlando Lopez, PhD
(301) 402-4243		 RFA-OD-20-020 R44 9/18/2020
NIH Directors Emergency Transformative Research Awards (R01 Clinical Trial Optional) Lillian Shum, PhD
(301) 204-0908		 RFA-RM-20-020 R01 9/30/2020
Emergency Awards: RADx-RAD Multimodal COVID-19 surveillance methods for high risk clustered populations (R01 Clinical Trial Optional) Dena Fischer, DDS, MSD, MS

(301) 594-4876

 RFA-OD-20-016 R01 9/30/2020
Emergency Awards: RADx-rad Data Coordination Center (DCC) (U24 Clinical Trial Not Allowed) Amanda Melillo, PhD
(301) 312-9037		 RFA-OD-20-019 U24 10/01/2020
Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements for Coronavirus Disease 2019 (COVID-19) Research within the Mission of NIDCR Dena Fischer, DDS, MSD, MS

(301) 594-4876

Preethi Chander, PhD
(301) 827-4620

Lynn King, PhD
(301) 594-5006

 NOT-DE-20-022 multiple, see announcement 11/02/2020
Notice of Special Interest (NOSI): Infrastructure Access for Research on Coronavirus Disease 2019 (COVID-19) Conducted in the National Dental Practice-Based Research Network Dena Fischer, DDS, MSD, MS

(301) 594-4876

 NOT-DE-20-023 multiple, see announcement 11/02/2020
Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional) Darien Weatherspoon, DDS, MPH
(301) 594-5394		 PAR-20-237 R01

12/01/2020

 

Last Reviewed
August 2020